Oncology

NICE recommends Intrabeam radiotherapy for breast cancer patients

The UK’s National Institute for Health and Care Excellence (NICE) has published guidance recommending the “controlled use of targeted breast cancer radiotherapy treatment alongside further research”. NICE said that it has recommended the Intrabeam Radiotherapy System for people...

Cancer rates in women ‘to rise faster than in men’

A new study has revealed that cancer rates will rise nearly six times faster in women than in men over the next 20 years. According to Cancer Research UK, it is predicted that UK cancer rates will increase by roughly 0.5 per cent for men and by approximately three per cent for women. This means...

Women treated for breast cancer precursor ‘live as long as others’

Women over the age of 50 who have been treated for ductal carcinoma in situ (DCIS) are more likely to be alive ten years later than women who have not, according to new research presented at the European Cancer Congress 2017. Led by Dr Jelle Wesseling, breast pathologist at the Netherlands Cancer...

Inflammation linked to breast cancer risk

Researchers have identified a link between breast cancer and a protein that causes inflammation. The scientists, from the Hospital Research Foundation (HRF) in Adelaide, Australia, have shown that chronic low-level inflammation drives increased breast density and is associated with a woman’s...

Young women ‘too embarrassed to attend cervical cancer screening’

More than one-quarter (26.7 per cent) of young women are too embarrassed to attend smear tests, while more than two thirds (70 per cent) don’t think they lower a woman’s risk of developing cervical cancer, according to new research. The study, conducted by UK charity Jo’s Cervical...

Some 42% of breast cancer patients experience severe side effects

A new study has revealed that almost half of all women suffering from breast cancer have reported that they have suffered serious side effects from their treatments. According to the researchers, led by the University of Michigan, US, side effects experienced by 42 per cent of breast cancer...

Cervical cancer mortality risk ‘may have been underestimated’

A new study has revealed that previous estimates may have underestimated the risk of death to women suffering from cervical cancer. According to a team of researchers from the Johns Hopkins Bloomberg School of Public Health, Maryland, US women's risk of dying from the disease may be...

Yellow fever vaccine linked to breast cancer risk reduction

Researchers at Italy’s University of Padova have claimed that the yellow fever vaccine could potentially reduce the risk of breast cancer. They have suggested that administering the yellow fever vaccine to women aged between 40 and 54 could halve the risk of developing breast cancer. During...

Mammograms linked to breast cancer overdiagnosis

Mammograms may result in healthy women being given unnecessary treatment for breast cancer, according to new research from the Nordic Cochrane Center and Rigshospitalet in Copenhagen, Denmark. The new study has provided evidence that links routine screening for breast cancer to an over-diagnosis of...

Existing drug could prevent spread of triple-negative breast cancer

New research has revealed that breast cancer metastasis may be prevented by a class of drugs that have already been approved in the US. Metastasis is the process by which cancer spreads. Researchers at the US’ Mayo Clinic have identified that enzyme pathway CDK4/6 regulates a cancer...